The effect of trehalose on stroke
Phase 2
Recruiting
- Conditions
- Ischemic stroke.Stroke, not specified as haemorrhage or infarction
- Registration Number
- IRCT20181022041407N7
- Lead Sponsor
- Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Patients with ischemic stroke
Age more than 18 years old
Satisfaction for participation in research project (by the patient or his guardian).
NISS score between 5-25 or less than 5 with aphasia, ataxia, or anopia.
Exclusion Criteria
Willingness to withdraw from the study
Pregnancy or breastfeeding
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method C-reactive protein (CRP). Timepoint: Baseline and after 5 days (or at the time of discharge in case of discharge earlier than 5 days). Method of measurement: Blood test.;Modified Rankin Scale (MRS). Timepoint: Baseline and after 5 days (or at the time of discharge in case of discharge earlier than 5 days), after 1 and 3 months of intervention. Method of measurement: Checklist.;Complete Blood Count (CBC). Timepoint: Baseline and after 5 days (or at the time of discharge in case of discharge earlier than 5 days). Method of measurement: Blood test.;National Institutes of Health Stroke Scale (NIHSS). Timepoint: Baseline and after 5 days (or at the time of discharge in case of discharge earlier than 5 days). Method of measurement: Checklist and physical examination.
- Secondary Outcome Measures
Name Time Method Assessment of stroke complication such as recurrent stroke, myocardial infarction (MI), transient ischemic attack (TIA), bleeding, mortality. Timepoint: Monthly for 3 months. Method of measurement: By asking questions from the patients.